96 related articles for article (PubMed ID: 6529537)
1. The effect of food on the oral absorption of isosorbide-5-mononitrate.
Laufen H; Leitold M
Br J Clin Pharmacol; 1984 Dec; 18(6):967-8. PubMed ID: 6529537
[No Abstract] [Full Text] [Related]
2. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
3. The effect of food on the absorption of slow-release isosorbide-5-mononitrate tablets.
Thomson AH; Miller SH; Green ST; Whiting B
Eur J Clin Pharmacol; 1988; 34(1):47-50. PubMed ID: 3360048
[TBL] [Abstract][Full Text] [Related]
4. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
5. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of isosorbide-5-mononitrate in humans.
Rameis H; Bacher S; Eichler HG; Horwatitsch H
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):678-80. PubMed ID: 4093207
[TBL] [Abstract][Full Text] [Related]
7. Isosorbide 5-mononitrate pharmacokinetics in humans.
Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
[TBL] [Abstract][Full Text] [Related]
8. Newer aspects of the pharmacokinetics of organic nitrates.
Chasseaud LF
Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
[TBL] [Abstract][Full Text] [Related]
9. Isosorbide 5-mononitrate kinetics.
Major RM; Taylor T; Chasseaud LF; Darragh A; Lambe RF
Clin Pharmacol Ther; 1984 May; 35(5):653-9. PubMed ID: 6713775
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
12. Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):129-35. PubMed ID: 3557738
[TBL] [Abstract][Full Text] [Related]
13. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
Bogaert MG; Rosseel MT; Boelaert J; Daneels R
Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
[No Abstract] [Full Text] [Related]
15. Isosorbide 5-mononitrate pharmacokinetics.
Chasseaud LF
Cardiology; 1987; 74 Suppl 1():6-11. PubMed ID: 3300979
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and bioavailability of a new slow-release isosorbide-5-mononitrate system].
Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E
Cardiologia; 1987 Nov; 32(11):1287-91. PubMed ID: 3447701
[No Abstract] [Full Text] [Related]
17. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
19. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
20. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions].
Rietbrock N; Knoll J; Merz PG; Menke G
Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
